Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment.
Mira
José A
JA
Servicio de Medicina Interna, Hospital Universitario de Valme, Sevilla, Spain.
Lozano
Fernando
F
Santos
Jesús
J
Ramayo
Emilia
E
Terrón
Alberto
A
Palacios
Rosario
R
León
Eva M
EM
Márquez
Manuel
M
Macías
Juan
J
Fernández-Palacin
Ana
A
Gómez-Mateos
Jesús
J
Pineda
Juan A
JA
D000328:Adult; D000368:Aged; D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D015331:Cohort Studies; D003521:Cyclopropanes; D016049:Didanosine / Q000009:adverse effects / Q000627:therapeutic use*; D006177:Gynecomastia / Q000097:blood / Q000139:chemically induced / Q000209:etiology*; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013739:Testosterone / Q000097:blood; D014280:Triglycerides / Q000097:blood
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D014280:Triglycerides; D013739:Testosterone; C098320:efavirenz; D016049:Didanosine